TF and cancer: As cancer cells undergo metabolic reprograming essential for cancer cell survival and growth (Vander Heiden et al., 2009), these findings point to a reversal of the metabolic reprograming of the cancer cells, originated from different cancer types, in response to R‐Tf‐D‐LP4 peptide action.